Cloned (Comment) | Organism |
---|---|
overexpression of Cdr1p as a GFP-tagged protein in plasma membrane of Saccharomyces cerevisiae | Candida albicans |
Protein Variants | Comment | Organism |
---|---|---|
A666G | the mutant shows an uncoupling of ATPase and drug transport and displays a selective loss of resistance to one or more of the tested drugs, the mutant displays a hyperresistant phenotype towards fluconazole comparable to wild type | Candida albicans |
F673A | the mutant shows a reduction in both Km and Vmax values of ATPase activity when compared to wild-type Cdr1p-GFP, and displays a selective loss of resistance to one or more of the tested drugs | Candida albicans |
G672A | the mutant shows an uncoupling of ATPase and drug transport and displays a selective loss of resistance to one or more of the tested drugs | Candida albicans |
I675A | the mutant shows a reduction in both Km and Vmax values of ATPase activity when compared to wild-type Cdr1p-GFP, and displays a selective loss of resistance to one or more of the tested drugs | Candida albicans |
L663A | the mutant shows an uncoupling of ATPase and drug transport and displays a selective loss of resistance to one or more of the tested drugs | Candida albicans |
L664A | the mutant shows an uncoupling of ATPase and drug transport and displays a selective loss of resistance to one or more of the tested drugs | Candida albicans |
M667A | the mutant shows a reduction in both Km and Vmax values of ATPase activity when compared to wild-type Cdr1p-GFP, and displays a selective loss of resistance to one or more of the tested drugs | Candida albicans |
additional information | substrate specificities of transmembrane segment mutants, overview | Candida albicans |
P659A | the mutant shows an uncoupling of ATPase and drug transport and displays a selective loss of resistance to one or more of the tested drugs | Candida albicans |
P676A | the mutant shows an uncoupling of ATPase and drug transport and displays a selective loss of resistance to one or more of the tested drugs | Candida albicans |
P678A | the mutant shows a reduction in both Km and Vmax values of ATPase activity when compared to wild-type Cdr1p-GFP, and displays a selective loss of resistance to one or more of the tested drugs | Candida albicans |
T671A | the mutant shows an uncoupling of ATPase and drug transport and displays a selective loss of resistance to one or more of the tested drugs | Candida albicans |
T677A | the mutant shows an uncoupling of ATPase and drug transport and displays a selective loss of resistance to one or more of the tested drugs | Candida albicans |
V668A | the mutant shows an uncoupling of ATPase and drug transport and displays a selective loss of resistance to one or more of the tested drugs | Candida albicans |
V674A | the mutant shows an uncoupling of ATPase and drug transport and displays a selective loss of resistance to one or more of the tested drugs | Candida albicans |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
1.58 | - |
ATP | pH 7.5, 30°C, recombinant mutant I675A | Candida albicans | |
2.68 | - |
ATP | pH 7.5, 30°C, recombinant mutant M667A | Candida albicans | |
2.7 | - |
ATP | pH 7.5, 30°C, recombinant mutant P678A | Candida albicans | |
3.62 | - |
ATP | pH 7.5, 30°C, recombinant mutant L663A | Candida albicans | |
3.62 | - |
ATP | pH 7.5, 30°C, recombinant mutant Y670A | Candida albicans | |
3.73 | - |
ATP | pH 7.5, 30°C, recombinant mutant L665A | Candida albicans | |
3.92 | - |
ATP | pH 7.5, 30°C, recombinant mutant P673A | Candida albicans | |
4.04 | - |
ATP | pH 7.5, 30°C, recombinant mutant I669A | Candida albicans | |
4.06 | - |
ATP | pH 7.5, 30°C, recombinant mutant L664A | Candida albicans | |
4.36 | - |
ATP | pH 7.5, 30°C, recombinant mutant T671A | Candida albicans | |
4.75 | - |
ATP | pH 7.5, 30°C, recombinant mutant V674A | Candida albicans | |
4.82 | - |
ATP | pH 7.5, 30°C, recombinant mutant P659A | Candida albicans | |
4.83 | - |
ATP | pH 7.5, 30°C, recombinant mutant P676A | Candida albicans | |
4.9 | - |
ATP | pH 7.5, 30°C, recombinant mutant T677A | Candida albicans | |
5.21 | - |
ATP | pH 7.5, 30°C, recombinant mutant G672A | Candida albicans | |
5.69 | - |
ATP | pH 7.5, 30°C, recombinant mutant V668A | Candida albicans | |
5.71 | - |
ATP | pH 7.5, 30°C, recombinant mutant V662A | Candida albicans | |
6.08 | - |
ATP | pH 7.5, 30°C, recombinant mutant A666G | Candida albicans | |
6.39 | - |
ATP | pH 7.5, 30°C, recombinant wild-type enzyme | Candida albicans | |
7.19 | - |
ATP | pH 7.5, 30°C, recombinant mutant A660G | Candida albicans | |
7.55 | - |
ATP | pH 7.5, 30°C, recombinant mutant T658A | Candida albicans |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
membrane | transmembrane protein | Candida albicans | 16020 | - |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Mg2+ | - |
Candida albicans |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + H2O + xenobiotic/in | Candida albicans | importance of Candida drug resistance protein Cdr1p of pathogenic Candida albicans in azole resistance | ADP + phosphate + xenobiotic/out | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Candida albicans | - |
- |
- |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
additional information | - |
substrate specificities of transmembrane segment mutants, overview | Candida albicans |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + H2O + anisomycin/in | - |
Candida albicans | ADP + phosphate + anisomycin/out | - |
? | |
ATP + H2O + beta-estradiol/in | - |
Candida albicans | ADP + phosphate + beta-estradiol/out | - |
? | |
ATP + H2O + cycloheximide /in | - |
Candida albicans | ADP + phosphate + cycloheximide /out | - |
? | |
ATP + H2O + fluconazole/in | - |
Candida albicans | ADP + phosphate + fluconazole/out | - |
? | |
ATP + H2O + itraconazole/in | - |
Candida albicans | ADP + phosphate + itraconazole/out | - |
? | |
ATP + H2O + ketoconazole/in | - |
Candida albicans | ADP + phosphate + ketoconazole/out | - |
? | |
ATP + H2O + miconazole/in | - |
Candida albicans | ADP + phosphate + miconazole/out | - |
? | |
ATP + H2O + oligomycin/in | - |
Candida albicans | ADP + phosphate + oligomycin/out | - |
? | |
ATP + H2O + progesterone/in | - |
Candida albicans | ADP + phosphate + progesterone/out | - |
? | |
ATP + H2O + rhodamine 6G/in | - |
Candida albicans | ADP + phosphate + rhodamine 6G/out | - |
? | |
ATP + H2O + xenobiotic/in | - |
Candida albicans | ADP + phosphate + xenobiotic/out | - |
? | |
ATP + H2O + xenobiotic/in | importance of Candida drug resistance protein Cdr1p of pathogenic Candida albicans in azole resistance | Candida albicans | ADP + phosphate + xenobiotic/out | - |
? |
Synonyms | Comment | Organism |
---|---|---|
Cdr1p | - |
Candida albicans |
multidrug resistance protein | - |
Candida albicans |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
30 | - |
assay at | Candida albicans |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.5 | - |
assay at | Candida albicans |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
ATP | - |
Candida albicans |